Current role
Biotechnology · Healthcare
Board Member
2026-08-14–present
Dannielle Appelhans
Board Member
Halozyme Therapeutics, Inc. (HALO)Equibles does not estimate personal net worth.
Get an email with a short summary when Halozyme Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get HALO alertsAbout Dannielle Appelhans
Dannielle Appelhans is recorded as Board Member at Halozyme Therapeutics, Inc. (HALO) since August 14, 2026. Halozyme Therapeutics, Inc. reported in an 8-K filed August 18, 2026 that Dannielle Appelhans was appointed Director, effective August 14, 2026. Halozyme Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Halozyme Therapeutics, Inc. includes Helen Torley (CEO and Board Member), Darren Snellgrove (CFO), Elaine D. Sun (CFO) and 7 others.
“On August 14, 2026, Dannielle Appelhans was elected to the Board of Directors of Halozyme Therapeutics, Inc. (the “Company”).”
Affiliation history
-
Current
2026-08-14–present
Company network
Leadership on record at Halozyme Therapeutics, Inc.
- Helen Torley CEO, Board Member
- Darren Snellgrove CFO
- Elaine D. Sun CFO
- Nicole LaBrosse CFO
- Cortney Caudill COO
- Mark Snyder General Counsel
- Barbara Duncan Board Member
- Bernadette Connaughton Board Member
- Connie L. Matsui Board Member
- James Daly Board Member